Back to search results

Cefiderocol and Ampicillin-sulbactam vs. Colistin +/- Meropenem for Carbapenem Resistant A. Baumannii

IsraelRecruitingPHASE4

Conditions

Carbapenem Resistant Bacterial Infection · Acinetobacter Bacteremia · Acinetobacter Pneumonia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Rambam Health Care Campus, Haifa, Israel

    Contact: Study coordinator (Mical Paul, MD) · m_paul@rambam.health.gov.il
    Contact: Principal Investigator (Mical Paul, MD)

  • Sheba Tel HaShomer Medical Campus, Ramat Gan, Israel

    Contact: Study coordinator (Dafna Dahav, MD)
    Contact: Principal Investigator (Dafna Yahav, MD)

  • Shamir Medical Center (Assaf Harofeh), Tel Aviv, Israel

    Contact: Study coordinator (Dror Marchaim)
Study leads

  • Marco Falcone

    Principal Investigator

    Pisa University Hospital

  • Dafna Yahav

    Principal Investigator

    Sheba Medical Center

  • Mical Paul

    Principal Investigator

    Rambam Health Care Campus

View source on ClinicalTrials.gov(opens in a new tab)